2019. Efficacy of Certolizumab Pegol for Psoriasis of the Head and Neck in Two Phase 3 Clinical Trials: CIMPASI-1 and CIMPASI-2. SKIN The Journal of Cutaneous Medicine. 3, (Nov. 2019), S40. DOI:https://doi.org/10.25251/skin.3.supp.40.